Clinical Trial Update: Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant chemotherapy with docetaxel, cisplatin, and capecitabine for locally advanced breast cancer. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED